Joshua Tinsley
Optometrist · Birmingham, ALNPI 1407383953
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 208 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations.
Across 208 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$688
- Alcon$531
- Mallinckrodt Hospital Products Inc.$384
- Eyevance Pharmaceuticals LLC$356
- Sun Pharmaceutical Industries Inc.$297
- Bausch & Lomb, A Division Of Bausch Health US, LLC$267
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,092100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $688 |
| Alcon | 24 | $531 |
| Mallinckrodt Hospital Products Inc. | 12 | $384 |
| Eyevance Pharmaceuticals LLC | 15 | $356 |
| Sun Pharmaceutical Industries Inc. | 16 | $297 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 20 | $267 |
| Novartis | 11 | $245 |
| Oyster Point Pharma, Inc. | 10 | $185 |
| Glaukos Corporation | 5 | $185 |
| Bausch & Lomb Americas Inc. | 10 | $170 |
| Aerie Pharmaceuticals, Inc. | 7 | $130 |
| Harrow Eye, LLC | 4 | $104 |
| Tarsus Pharmaceuticals, Inc. | 6 | $97 |
| Astellas Pharma US Inc | 5 | $87 |
| Genentech USA, Inc. | 4 | $84 |
| Sight Sciences, Inc. | 3 | $55 |
| Apellis Pharmaceuticals, Inc. | 2 | $53 |
| ANI Pharmaceuticals, Inc. | 3 | $49 |
| Mallinckrodt Enterprises LLC | 2 | $37 |
| Kala Pharmaceuticals, Inc. | 1 | $25 |
| Rxsight Inc | 1 | $24 |
| Biotissue Holdings Inc. | 1 | $16 |
| Dompe US, Inc. | 1 | $14 |
| Eyepoint US, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PHOTREXA CROSS-LINKING KIT$113
- Flarex$111
How this compares
$4,092 in reported general payments places this provider in the 85th percentile of 749 optometrist providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 16 | $651 |
| ErythromycinErythromycin Base | 12 | $138 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Birmingham
- Kelly NicholsBirmingham$231K
- Leo SemesBirmingham$60K
- Andrew PuckerBirmingham$27K
- Ashley SavageBirmingham$9K
- Ami EpsteinBirmingham$8K
- Caroline PateBirmingham$6K
- Casey BrownBirmingham$5K
- Valencia WellsBirmingham$5K
- Nicholas OnkenBirmingham$5K
- Mark SchaefferHoover$470K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.